Results
|
7101.
|
|
|
7102.
|
Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms. [electronic resource] by
- Coudray, Anne-Marie
- Louvet, Christophe
- Kornprobst, Michel
- Raymond, Eric
- André, Thierry
- Tournigand, Christophe
- Faivre, Sandrine
- De Gramont, Aimery
- Larsen, Annette K
- Gespach, Christian
Producer: 20051223
In:
International journal of oncology vol. 27
Availability: No items available.
|
|
7103.
|
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. [electronic resource] by
- Roth, Arnaud D
- Delorenzi, Mauro
- Tejpar, Sabine
- Yan, Pu
- Klingbiel, Dirk
- Fiocca, Roberto
- d'Ario, Giovanni
- Cisar, Laura
- Labianca, Roberto
- Cunningham, David
- Nordlinger, Bernard
- Bosman, Fred
- Van Cutsem, Eric
Producer: 20130111
In:
Journal of the National Cancer Institute vol. 104
Availability: No items available.
|
|
7104.
|
Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells. [electronic resource] by
- Tanaka, Tetsuji
- Bai, Tao
- Toujima, Saori
- Utsunomiya, Tomoko
- Matsuoka, Toshihide
- Kobayashi, Aya
- Yamamoto, Madoka
- Sasaki, Noriyuki
- Tanizaki, Yuko
- Utsunomiya, Hirotoshi
- Tanaka, Junko
- Yukawa, Kazunori
Producer: 20120530
In:
Oncology reports vol. 27
Availability: No items available.
|
|
7105.
|
Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. [electronic resource] by
- Wang, Wenge
- Gallant, Jean-Nicolas
- Katz, Sharyn I
- Dolloff, Nathan G
- Smith, Charles D
- Abdulghani, Junaid
- Allen, Joshua E
- Dicker, David T
- Hong, Bo
- Navaraj, Arunasalam
- El-Deiry, Wafik S
Producer: 20120206
In:
Cancer biology & therapy vol. 12
Availability: No items available.
|
|
7106.
|
|
|
7107.
|
|
|
7108.
|
Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells. [electronic resource] by
- Dai, Xiao-Yang
- Zhuang, Lin-Han
- Wang, Dan-Dan
- Zhou, Tian-Yi
- Chang, Lin-Lin
- Gai, Ren-Hua
- Zhu, Di-Feng
- Yang, Bo
- Zhu, Hong
- He, Qiao-Jun
Producer: 20161223
In:
Oncotarget vol. 7
Availability: No items available.
|
|
7109.
|
|
|
7110.
|
|
|
7111.
|
|
|
7112.
|
Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. [electronic resource] by
- Emmink, Benjamin L
- Van Houdt, Winan J
- Vries, Robert G
- Hoogwater, Frederik J H
- Govaert, Klaas M
- Verheem, Andre
- Nijkamp, Maarten W
- Steller, Ernst J A
- Jimenez, Connie R
- Clevers, Hans
- Borel Rinkes, Inne H M
- Kranenburg, Onno
Producer: 20110907
In:
Gastroenterology vol. 141
Availability: No items available.
|
|
7113.
|
|
|
7114.
|
Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. [electronic resource] by
- Ogino, Shuji
- Meyerhardt, Jeffrey A
- Cantor, Mami
- Brahmandam, Mohan
- Clark, Jeffrey W
- Namgyal, Chungdak
- Kawasaki, Takako
- Kinsella, Kate
- Michelini, Ann L
- Enzinger, Peter C
- Kulke, Matthew H
- Ryan, David P
- Loda, Massimo
- Fuchs, Charles S
Producer: 20051108
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11
Availability: No items available.
|
|
7115.
|
|
|
7116.
|
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. [electronic resource] by
- Scartozzi, M
- Giampieri, R
- Maccaroni, E
- Mandolesi, A
- Giustini, L
- Silva, R
- Zaniboni, A
- Biscotti, T
- Biagetti, S
- Galizia, E
- Loupakis, F
- Falcone, A
- Bearzi, I
- Cascinu, S
Producer: 20121022
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
7117.
|
|
|
7118.
|
Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1. [electronic resource] by
- Xu, Li
- Zhu, Yuanrun
- Shao, Jinjin
- Chen, Min
- Yan, Hao
- Li, Guanqun
- Zhu, Yi
- Xu, Zhifei
- Yang, Bo
- Luo, Peihua
- He, Qiaojun
Producer: 20170606
In:
British journal of cancer vol. 116
Availability: No items available.
|
|
7119.
|
|
|
7120.
|
|